Stock Analysis
Adaptive Biotechnologies Corporation (ADPT) Stock Analysis
Adaptive Biotechnologies Corporation (ADPT) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Adaptive Biotechnologies Corporation (ADPT) currently has an AIQ Score of 41/100, indicating a neutral setup. Sentiment is the strongest factor at 73/100. Risk is the weakest current factor at 27/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
ADPT at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $26.64 |
| AIQ Score | 41/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $3.9B |
| P/E Ratio (TTM) | -59.74 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | -$0.25 |
| Revenue (quarter ended 2026-06-30) | $71.55M |
| Dividend Yield (TTM) | 0.00% |
| Beta | 2.09 |
| Volume | 4.83M |
| 52-week range | $12.00-$30.74 |
| RSI 14 | 58.68 |
| 50-Day SMA | $26.35 |
| 200-Day SMA | $19.56 |
| Analyst Price Target | $28.15 |
| Next Earnings | Nov 4, 2026 |
ADPTAdaptive Biotechnologies Corporation
Healthcare / Biotechnology
Low Priority
Relative Laggard
Latest quote
- Momentum70
- Value34
- Quality30
- Risk resilience27
- Sentiment73
ADPT Stock Analysis Summary
Adaptive Biotechnologies Corporation (ADPT) currently has an AIQ Score of 41/100, indicating a neutral setup. Sentiment is the strongest factor at 73/100. Risk resilience is the weakest current factor at 27/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, ADPT has AIQ Score of 41/100 with Sentiment base of 73/100 and fading Risk resilience at 27/100. Wait for component alignment before adding exposure.
Sentiment (73/100) leads while Risk resilience (27/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -5.43% stock move · ADPT classified in Biotechnology.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is ADPT Bullish or Bearish Right Now?
ADPT currently has a neutral overall setup. Sentiment is the strongest factor at 73/100, while Risk Resilience is weakest at 27/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 70/100.
- - Price is +6.89% above its 50-day SMA.
- - Analyst target implies +5.67% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (33 vs 10).
- - Value is the current constraint at 34/100.
- - Risk Resilience is weak at 27/100.
Current Consensus
ADPT's Technical Analysis Consensus is currently Strong Buy, with 33 buy, 2 neutral, and 10 sell votes. ADPT's 14-day RSI is 58.68, which places the stock in a constructive momentum range. ADPT's beta is 2.09, indicating greater market sensitivity than the broad market.
What Changed in ADPT?
The largest recent change in ADPT is Momentum moving up by 37.0 points over the available 7-day comparison window. Sentiment remains the strongest visible factor.
What Would Change the ADPT Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
ADPT Decision Framework
Public evidence layers, setup checks, and risk context for Adaptive Biotechnologies Corporation.
Adaptive Biotechnologies Corporation (ADPT) Stock Analysis
Adaptive Biotechnologies Corporation has an AIQ Score of 41/100 in a Neutral regime. Sentiment is strongest at 73/100. Beta is 2.1, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | ADPT is in a Neutral AIQ regime with score 41/100. |
| Signal Conflict | The primary conflict is that sentiment leads at 73/100 while risk lags at 27/100. |
| Factor Evidence | Momentum 70/100 · Value 34/100 · Quality 30/100 · Risk 27/100 · Sentiment 73/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Sentiment is the strongest factor at 73/100.
Momentum is 70/100 and RSI (14) is 58.7.
ADPT is in a Neutral regime at 41/100.
Risk factor is 27/100 with beta 2.1 and annual volatility 66.88%.
Current conflict: sentiment leads at 73/100 while risk lags at 27/100.
ADPT Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
ADPT Fundamentals
ADPT valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
ADPT Technical Analysis
ADPT technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
ADPT Stock Catalysts
Track ADPT earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
ADPT Dividend Analysis
ADPT dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
ADPT Financial Data
ADPT revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
ADPT Risk Analysis
ADPT volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
ADPT Stock News
ADPT stock news, market tone, recent headlines, and catalyst context.
ADPT vs Internet / Consumer Tech Peers
Current peer cohort: ADPT · ALRM · API · CHGG · COMP. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| ADPT Current stock | 41/100 | 34/100 | 70/100 | 27/100 | 1.05 | 66.88% | Current |
| ALRM Alarm.com | 69/100 | 67/100 | 79/100 | 69/100 | 1.03 | 30.11% | ADPT vs ALRM |
| API Agora | 62/100 | 53/100 | 75/100 | 64/100 | 0.64 | 49.58% | ADPT vs API |
| CHGG Chegg | 47/100 | 65/100 | 36/100 | 25/100 | 0.06 | 103.85% | ADPT vs CHGG |
| COMP Compass | 32/100 | 42/100 | 42/100 | 19/100 | 0.58 | 66.11% | ADPT vs COMP |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 29, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts4 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching ADPT
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for ADPT
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
ADPT Stock FAQ
What is ADPT stock price today?
Adaptive Biotechnologies Corporation's current stock price is $26.64. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is ADPT bullish or bearish right now?
ADPT's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is ADPT's market cap?
ADPT's market cap is $3.9B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is ADPT's current P/E ratio?
ADPT's current P/E ratio is -59.74 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is ADPT's RSI?
ADPT's 14-day RSI is 58.68 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is ADPT above its 50-day and 200-day moving averages?
ADPT is 6.89% from its 50-day SMA and 44.02% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is ADPT's next earnings date?
ADPT's next earnings date is currently listed as Nov 4, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does ADPT pay a dividend?
ADPT's dividend yield is 0.00% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.